KevMed Prepares to Introduce Novel Device for Pelvic Pain and Interstitial Cystitis as US Distributor of PainShield

Share Article

KevMed announces that it has been appointed as the US distributor of the PainShield device for treatment of pelvic pain and related conditions by NanoVibronix, a company that develops innovative medical products based on its proprietary miniaturised ultrasound technology. PainShield is a wearable device that delivers low frequency, therapeutic ultrasound for the treatment of pain associated with a number of pelvic and abdominal conditions including interstitial cystitis, irritable bowel syndrome and chronic pelvic pain.

Chronic Pelvic Pain Treatment


We have a real chance to revolutionize pelvic pain treatment without the risks of surgery or drugs.

NanoVibronix®, Inc., a medical device company, which develops innovative therapeutic ultrasound products, has named KevMed™, LLC as its US distributor for PainShield®, the first hands-free, wearable therapeutic ultrasound device to treat the over 15 million patients in the USA with pelvic pain, interstitial cystitis and related conditions.

With over 25 years of experience in the area of abdominal adhesions and pelvic pain syndromes, David Wiseman, PhD, President of KevMed is excited to introduce the PainShield device to help alleviate pelvic pain in patients with chronic and difficult to treat symptoms. "In a clinical study, we found the PainShield ultrasound therapy to dramatically reduce pain in CAPPS (Complex Abdominal and Pelvic Pain Syndrome) patients. An abstract with clinical data reflecting this positive finding was accepted for presentation at the upcoming meeting of the International Pelvic Pain Society (IPPS) 2012 in Chicago," says Wiseman. "I feel that for the first time, we have a real chance to revolutionize the management of pain in these patients without the risks of surgery or drugs."

According to Amir Rippel, VP Marketing at NanoVibronix, "our relationship with KevMed will allow us to reach many patients suffering from pain due to various pelvic pain syndromes. PainShield can help pelvic pain patients overcome their daily suffering and return to a more normal life." Rippel adds, "following our ongoing success in relieving pain for patients with trigeminal neuralgia, an extremely painful neurological facial syndrome, we believe we can reduce the suffering and improve quality of life for many other patients with specific, but difficult to treat pain."

PainShield is the first hands-free, low-frequency therapeutic ultrasound device that delivers therapy via a self-adhering patch. The portable design allows for an entirely new dimension in ultrasound treatment of pain and soft tissue healing. PainShield consists of a disposable patch connected to a portable reusable driver and transmits ultrasound waves to the desired area of the body. Patients can use PainShield in the clinical setting, at home, at work, and even while they sleep. The hassle-free, user-friendly application of the device dramatically improves patient compliance and access to treatment. PainShield is cleared by the FDA for treatment of pain and carries the CE Mark.

Over 15 million patients in the US suffer from a number of overlapping disorders that include pelvic pain, abdominal pain, Adhesion Related Disorder (ARD), bowel obstruction, endometriosis, interstitial cystitis (IC), painful bladder syndrome, irritable bowel syndrome (IBS), vulvodynia, dyspareunia (painful intercourse), dyschezia (painful defecation), adhesions, sacroiliac joint pain, pudendal neuralgia and pelvic floor dysfunction. Numerous patients undergo hysterectomy in an effort to alleviate their pain, only to discover that the procedure worsens their condition. In extreme cases, patients will also report fibromyalgia, temporomandibular joint (TMJ) disorders (TMD) and reflex sympathetic dystrophy (RSD) or complex regional pain syndrome (CRPS). Collectively, these conditions have been termed CAPPS (Complex Abdominal and Pelvic Pain Syndrome). PainShield is designed to help relieve the pain associated with these conditions.

About KevMed
KevMed, LLC was born from the work of the International Adhesions Society (IAS), which provides information, support, and advocacy to patients and their families suffering from Adhesion Related Disorder (ARD) and Complex Abdominal and Pelvic Pain Syndrome (CAPPS). The International Adhesions Society (IAS) was founded by Synechion, Inc. in 1996 in response to demand by pelvic pain patients seeking answers in a field that remains poorly understood by many patients and clinicians. Synechion, Inc. is a consulting company specializing in the science and business of adhesions, founded by David Wiseman, PhD, MRPharmS, internationally recognized expert who has been making important product and scientific contributions to the field since 1987. Research by the International Adhesions Society (IAS) has revealed new understandings of Adhesion Related Disorder (ARD) and related conditions from the perspective of the patient, resulting in the identification of PainShield® as an effective treatment for pelvic pain.

Dr. David Wiseman, President
KevMed™, LLC
15305 Dallas Parkway, Suite 300, Addison, TX 75001
972 931 5596
About NanoVibronix®
Located in Farmingdale, New York, with a subsidiary in Nesher, Israel, NanoVibronix® develops medical devices that utilize its proprietary therapeutic ultrasound technology. In addition to the PainShield® product for pain, the company is expanding its portable, therapeutic platform to the WoundShield® device - targeting expedited healing of chronic and acute wounds. NanoVibronix has also developed and markets the UroShield® catheter-based, disposable ultrasound, intended to reduce pain and discomfort and help prevent UTI in indwelling urinary catheters.

Amir Rippel
NanoVibronix Ltd.
Tel: +972 4 820 0581

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Wiseman, PhD
Visit website